ArticleFrontiers in cellular neuroscience2019

Presymptomatic Treatment With Andrographolide Improves Brain Metabolic Markers and Cognitive Behavior in a Model of Early-Onset Alzheimer's Disease.

Pedro Cisternas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.